Mexico - Delayed Quote MXN
Regeneron Pharmaceuticals, Inc. (REGN.MX)
At close: November 6 at 2:33 PM CST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
4,247,400.00
4,594,000.00
5,014,900.00
7,081,300.00
2,618,100.00
Investing Cash Flow
-2,884,900.00
-3,185,100.00
-3,784,600.00
-5,384,700.00
-70,600.00
Financing Cash Flow
-1,511,100.00
-1,790,100.00
-1,009,000.00
-1,005,800.00
-1,970,500.00
End Cash Position
2,011,600.00
2,737,800.00
3,119,400.00
2,898,100.00
2,207,300.00
Income Tax Paid Supplemental Data
--
870,300.00
1,502,400.00
1,218,400.00
188,100.00
Interest Paid Supplemental Data
--
73,100.00
53,700.00
55,800.00
23,200.00
Capital Expenditure
-928,100.00
-926,400.00
-1,616,900.00
-551,900.00
-614,600.00
Issuance of Capital Stock
1,675,400.00
1,145,500.00
1,519,500.00
1,672,300.00
2,575,200.00
Issuance of Debt
--
--
--
--
3,481,900.00
Repayment of Debt
--
--
--
--
-1,500,000.00
Repurchase of Capital Stock
-3,153,100.00
-2,935,600.00
-2,528,500.00
-2,678,100.00
-6,527,600.00
Free Cash Flow
3,319,300.00
3,667,600.00
3,398,000.00
6,529,400.00
2,003,500.00
12/31/2020 - 1/8/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade